Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Lundbeck and Otsuka to collaborate in CNS

November 11, 2011 Research and Development, Sales and Marketing Abilify, CNS, Lundbeck, Otsuka

Lundbeck and Otsuka have signed a major collaborative deal to sell and develop up to five CNS drugs, including a …
News

Coulter Partners appoint Graham Dowsett, and Tarquin Bennett-Coles

November 11, 2011 Research and Development, Sales and Marketing Coulter Partners, recruitment

Graham Dowsett, and Tarquin Bennett – Coles have joined Coulter Partners’ senior management team. Coulter Partners is a leading Executive …
Appointment
Roche pic

Roche’s skin cancer drug receives FDA priority review

November 9, 2011 Research and Development, Sales and Marketing Roche, vismodegib

Roche’s skin cancer pill vismodegib will receive a priority review from the FDA which could see it approved within six …
News

Timothy Wright appointed as global head of development at Novartis Pharmaceuticals

November 9, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis has appointed Dr Timothy Wright as the new global head of development of its pharmaceuticals business, effective immediately.  Dr …
Appointment

Edge Medical Communications makes two senior appointments

November 9, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edge Medical, Medical comms

Edge Medical Communications has appointed Dr Laurence De-Netto as account director and Dr Elizabeth Rapley as business development manager. Dr …
Appointment
Lilly HQ picture

Amylin to pay up to $1.6 billion to sever ties with Lilly

November 8, 2011 Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, R&D, lilly

Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …
News

Strategic alliance executives

November 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTPartners, Strategic alliance executives

Given the extraordinary costs and risks associated with drug discovery and development, it’s not surprising that an increasing number of …
Feature

AZ and Targacept’s novel depression drug misses target

November 8, 2011 Research and Development, Sales and Marketing AstraZeneca

AstraZeneca and Targacept’s next generation depression drug has failed to meet its primary endpoint in a late-stage trial. The first …
News

UK pharma downbeat on its future – survey

November 8, 2011 Research and Development ABPI, R&D, VBP, rsa

The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …
News

Daniel Grau appointed as president of Heptares

November 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Grau, Heptares

Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors.  Mr Grau has been a …
Appointment
Pfizer Sandwich image

Pfizer to retain an extra 300 jobs at Sandwich site

November 8, 2011 Manufacturing and Production, Research and Development Jobs, Pfizer, Sandwich

Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …
News
david_roblin__picture_o

Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma

November 7, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D

Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …
Appointment

Aslan licences promising cancer drug from Bristol-Myers Squibb

November 7, 2011 Research and Development, Sales and Marketing Aslan, BMS, Cancer

Bristol-Myers Squibb has licensed one of its investigational oncology compounds, for the treatment of multiple solid tumours, to Singapore-based Aslan …
News
steve_hobbsrgb

Steve Hobbs joins Apodi senior management team

November 4, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Steve Hobbs has joined Apodi’s senior management team as director of business and account development. Steve has over 30 years …
Appointment

Graham Higson joins NDA Group to lead Regulatory and HTA Advisory Board

November 4, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA

GE Healthcare and ex AstraZeneca Head of Global Regulatory Affairs, Graham Higson, will join NDA Group in January 2012 to …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026